CHRS Coherus Oncology, Inc.
Executive Summary
In Q3 2024, a small group of asset managers increased CHRS holdings by $795K, while Temasek Holdings fully exited a $10.1M position. The net institutional flow is negative at $9.3M, with Temasek's exit overwhelming accumulation. Historical analysis shows this ticker has underperformed after institutional cluster filings, suggesting caution.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$9.3M
▲ Buyers (7)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Los Angeles Capital Management | DOUBLED | +344.1% | $967.0K | $605.0K |
| STRS Ohio | DOUBLED | +263% | $357.0K | $193.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Temasek Holdings (Private) | EXIT | -100% | $10.1M | -$10.1M |
| Nisa Investment Advisors | NEAR_EXIT | -80.6% | $36.0K | -$31.6K |
| Pnc Financial Services Group | TRIM | -64.2% | $474.00 | -$372.00 |
Actionable Insight
Temasek's full exit is a strong negative signal reflecting loss of institutional confidence. The 45-day 13F lag means these positions may already be unwound; monitor for further selling or negative catalysts. The small buying side lacks the conviction to offset the sovereign exit.
Key Facts
- 7 institutional buyers accumulated $1.4M in CHRS (net +$795K) while 3 sellers reduced by $10.1M (net -$9.3M).
- Temasek Holdings exited a $10.1M position (5.82M shares) — the dominant seller.
- Los Angeles Capital Management doubled its stake to 930K shares ($967K value).
- STRS Ohio doubled to 343K shares ($357K value).
- Nisa Investment Advisors nearly exited (trimmed 80.6% to 4K shares).
Financial Impact
Net institutional selling of $9.3M in Q3 2024, driven by Temasek's full exit of $10.1M offset by $1.4M in accumulation from 7 asset managers.
Risk Factors
- Continued institutional selling pressure given Temasek's complete exit.
- Low liquidity and high volatility typical of micro-cap biotech.
- Negative clinical or regulatory news that may have prompted the exit.
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CHRS-2024-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 15, 2026
3d ago
|
8-K
| $1.38 $1.39 | ▲ +0.72% | ▲ +1.97% | — |
|
Jun 12, 2026
6d ago
|
Institutional Cluster
| $1.40 $1.36 | ▲ +2.86% | ▲ +4.62% | — |
|
May 28, 2026
21d ago
|
DEFA14A
| $1.65 $1.59 | ▼ −3.64% | ▼ −3.88% | — |
|
May 11, 2026
5w ago
|
Press Release
| $1.71 $1.71 | · 0.00% | ▼ −0.54% | — |
|
May 5, 2026
6w ago
|
DEFA14A
| $1.75 $1.76 | ▲ +0.57% | ▲ +0.90% | — |
|
May 4, 2026
6w ago
|
Press Release
| $1.73 $1.79 | ▲ +3.47% | ▲ +2.67% | — |
|
Mar 9, 2026
14w ago
|
Press Release
| $1.95 $1.78 | ▼ −8.72% | ▼ −8.61% | — |
|
Mar 2, 2026
15w ago
|
Press Release
| $1.65 $1.65 | · 0.00% | ▲ +0.91% | — |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $1.65 $1.65 | · 0.00% | ▲ +0.91% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access